Ferguson Wellman Capital Management, Inc Biogen Inc. Transaction History

Ferguson Wellman Capital Management, Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 11, 2024	SELL	$222.59 - $267.94 $890 - $1,071	-4 Reduced 0.31%	1,275 $329,000
Q3 2023 Oct 12, 2023	BUY	$253.3 - $285.89 $1,013 - $1,143	4 Added 0.31%	1,279 $328,000
Q1 2023 Apr 20, 2023	SELL	$256.56 - $292.34 $3,078 - $3,508	-12 Reduced 0.93%	1,275 $354,000
Q3 2022 Oct 17, 2022	BUY	$194.69 - $268.46 $2,530 - $3,489	13 Added 1.02%	1,287 $344,000
Q1 2022 Apr 14, 2022	BUY	$193.77 - $244.14 $246,862 - $311,034	1,274 New	1,274 $268,000
Q2 2019 Jul 16, 2019	SELL	$219.29 - $241.72 $228,938 - $252,355	-1,044 Closed	0 $0
Q1 2019 Apr 11, 2019	SELL	$216.71 - $338.96 $514,902 - $805,368	-2,376 Reduced 69.47%	1,044 $247,000
Q4 2018 Jan 16, 2019	SELL	$278.5 - $352.75 $11.4 Million - $14.4 Million	-40,864 Reduced 92.28%	3,420 $1.03 Million
Q3 2018 Oct 25, 2018	SELL	$293.51 - $383.83 $9.95 Million - $13 Million	-33,889 Reduced 43.35%	44,284 $15.6 Million
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $184,126 - $219,440	-715 Reduced 0.91%	78,173 $22.7 Million
Q1 2018 Apr 09, 2018	BUY	$260.13 - $367.91 $45,262 - $64,016	174 Added 0.22%	78,888 $21.6 Million
Q4 2017 Jan 24, 2018	SELL	$307.64 - $344.58 $39,993 - $44,795	-130 Reduced 0.16%	78,714 $25.1 Million
Q3 2017 Oct 11, 2017	BUY	$281.15 - $329.69 $22.2 Million - $26 Million	78,844	78,844 $24.7 Million

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Ferguson Wellman Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Ferguson Wellman Capital Management, Inc with notifications on news.